VCRE
Vicore Pharma Holding AB
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$11.59
+0.35%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5417.02x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 35.34x
- Price / sales
- 2339.64x
- Price / cash flow
- -13.78x
Enterprise value
- Enterprise value
- $316.5M
- EV / sales
- 2269.41x
- EV / EBITDA
- -12.14x
- EV / EBIT
- -10.58x
- Market cap
- $326.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026